Genetic heterogeneity of Alzheimer's disease: Complexity and advances

Psychoneuroendocrinology

Volumn 32, Issue SUPPL 1, 2007, Pages

  Lambert, Jean Charles ^a   Amouyel, Philippe ^a  

^a INSERM   (France)

Author keywords

APOE; APP; Monogenic; Polymorphism; PS1; PS2; Sporadic

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; GLUTATHIONE TRANSFERASE; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 10; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FAMILIAL DISEASE; GENE MUTATION; GENETIC RISK; HUMAN; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FEMALE; HUMANS; INHERITANCE PATTERNS; MALE; SEX FACTORS;

EID: 34547669095     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.05.015     Document Type: Article

References (69)

1. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease, 1995. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA 274, 1627-1629.
2. Basun H., Grut M., Winblad B., and Lannfelt L. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci. Lett. 183 (1995) 32-34
3. Bertram L., and Tanzi R.E. The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115 (2005) 1449-1457
4. Bertram L., Hsiao M., Lange C., Blacker D., and Tanzi R.E. Single-nucleotide polymorphism rs498055 on chromosome 10q24 is not associated with Alzheimer disease in two independent family samples. Am. J. Hum. Genet. 79 (2006) 180-183
5. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39 (2007) 17-23
6. Breitner J.C., and Murphy E.A. Twin studies of Alzheimer disease: II. Some predictions under a genetic model. Am. J. Med. Genet. 44 (1992) 628-634
7. Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., and Frebourg T. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65 (1999) 664-670
8. Crentsil V. The pharmacogenomics of Alzheimer's disease. Ageing Res. Rev. 3 (2004) 153-169
9. Crutcher K.A., Clay M.A., Scott S.A., Tian X., Tolar M., and Harmony J.A. Neurite degeneration elicited by apolipoprotein E peptides. Exp. Neurol. 130 (1994) 120-126
10. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., and Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66 (2000) 196-204
11. Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine B.A., Factor S.A., Ferrarese C., Hadjigeorgiou G.M., Higgins D.S., Kawakami H., Kruger R., Marder K.S., Mayeux R.P., Mellick G.D., Nutt J.G., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Southwick A., Myers R.M., and Trikalinos T.A. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 5 (2006) 917-923
12. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and alzheimer disease meta analysis consortium. JAMA 278 (1997) 1349-1356
13. Farrer L.A., Bowirrat A., Friedland R.P., Waraska K., Korczyn A.D., and Baldwin C.T. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum. Mol. Genet. 12 (2003) 415-422
14. Gatz M., Pedersen N.L., Berg S., Johansson B., Johansson K., Mortimer J.A., Posner S.F., Viitanen M., Winblad B., and Ahlbom A. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J. Gerontol. A: Biol. Sci. Med. Sci. 52 (1997) M117-M125
15. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., and Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63 (2006) 168-174
16. Geerlings M.I., Ruitenberg A., Witteman J.C., van Swieten J.C., Hofman A., van Duijn C.M., Breteler M.M., and Launer L.J. Reproductive period and risk of dementia in postmenopausal women. JAMA 285 (2001) 1475-1481
17. Gibson G.E., Haroutunian V., Zhang H., Park L.C., Shi Q., Lesser M., Mohs R.C., Sheu R.K., and Blass J.P. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann. Neurol. 48 (2000) 297-303
18. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., and James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
19. Grupe A., Li Y., Rowland C., Nowotny P., Hinrichs A.L., Smemo S., Kauwe J.S., Maxwell T.J., Cherny S., Doil L., Tacey K., van Luchene R., Myers A., Wavrant-De Vrieze F., Kaleem M., Hollingworth P., Jehu L., Foy C., Archer N., Hamilton G., Holmans P., Morris C.M., Catanese J., Sninsky J., White T.J., Powell J., Hardy J., O'Donovan M., Lovestone S., Jones L., Morris J.C., Thal L., Owen M., Williams J., and Goate A. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am. J. Hum. Genet. 78 (2006) 78-88
20. Gureje O., Ogunniyi A., Baiyewu O., Price B., Unverzagt F.W., Evans R.M., Smith-Gamble V., Lane K.A., Gao S., Hall K.S., Hendrie H.C., and Murrell J.R. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann. Neurol. 59 (2006) 182-185
21. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997) 154-159
22. Holtzman D.M. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17 (2001) 147-155
23. Holtzman D.M., Bales K.R., Wu S., Bhat P., Parsadanian M., Fagan A.M., Chang L.K., Sun Y., and Paul S.M. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103 (1999) R15-R21
24. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., and Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97 (2000) 2892-2897
25. Kamboh M.I. Molecular genetics of late-onset Alzheimer's disease. Ann. Hum. Genet. 68 (2004) 381-404
26. Khachaturian A.S., Corcoran C.D., Mayer L.S., Zandi P.P., and Breitner J.C. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache county study. Arch. Gen. Psychiatry 61 (2004) 518-524
27. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
28. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K.R., and Paul S.M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10 (2004) 719-726
29. Kolsch H., Linnebank M., Lutjohann D., Jessen F., Wullner U., Harbrecht U., Thelen K.M., Kreis M., Hentschel F., Schulz A., von Bergmann K., Maier W., and Heun R. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63 (2004) 2255-2260
30. Koudinov A.R., Berezov T.T., and Koudinova N.V. Alzheimer's amyloid beta and lipid metabolism: a missing link?. FASEB J. 12 (1998) 1097-1099
31. Kuwano R., Miyashita A., Arai H., Asada T., Imagawa M., Shoji M., Higuchi S., Urakami K., Kakita A., Takahashi H., Tsukie T., Toyabe S., Akazawa K., Kanazawa I., and Ihara Y. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Hum. Mol. Genet. 15 (2006) 2170-2182
32. Lahiri D.K. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. J. Mol. Neurosci. 23 (2004) 225-233
33. Lambert J.C., Mann D., Richard F., Tian J., Shi J., Thaker U., Merrot S., Harris J., Frigard B., Iwatsubo T., Lendon C., and Amouyel P. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?. J. Neurol. Neurosurg. Psychiatry 76 (2005) 928-933
34. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., and Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104 (1999) R25-R31
35. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., and Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
36. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Gogic G., Chan J., Cravchik A., Ross D., Lau K., Kwok S., Chang S.Y., Catanese J., Sninsky J., White T.J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Owen M., Williams J., Goate A., and Grupe A. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. USA 101 (2004) 15688-15693
37. Li Y.J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., Hauser M.A., Scott W.K., Small G.W., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Goetz C.G., Mastaglia F., Middleton L.T., Roses A.D., Saunders A.M., Schmechel D.E., Gullans S.R., Haines J.L., Gilbert J.R., Vance J.M., Pericak-Vance M.A., Hulette C., and Welsh-Bohmer K.A. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet. 12 (2003) 3259-3267
38. Lin P.I., Martin E.R., Bronson P.G., Browning-Large C., Small G.W., Schmechel D.E., Welsh-Bohmer K.A., Haines J.L., Gilbert J.R., and Pericak-Vance M.A. Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease. Neurology 67 (2006) 64-68
39. Lowenberg K., and Waggoner R. Familial organic psychosis (Alzheimer's type). Arch. Neurol. Psychiatry 31 (1934) 737
40. Luc G., Bard J.M., Arveiler D., Evans A., Cambou J.P., Bingham A., Amouyel P., Schaffer P., Ruidavets J.B., and Cambien F. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arterioscler. Thromb. 14 (1994) 1412-1419
41. Manelli A.M., Stine W.B., Van Eldik L.J., and LaDu M.J. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J. Mol. Neurosci. 23 (2004) 235-246
42. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., and Ballinger D.G. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77 (2005) 685-693
43. Meyer M.R., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Steffens D.C., Wyse B.W., and Breitner J.C. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat. Genet. 19 (1998) 321-322
44. Minster R.L., DeKosky S.T., and Kamboh M.I. Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease. Neurosci. Lett. 408 (2006) 170-172
45. Miyata M., and Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14 (1996) 55-61
46. Naruse S., Thinakaran G., Luo J.J., Kusiak J.W., Tomita T., Iwatsubo T., Qian X., Ginty D.D., Price D.L., Borchelt D.R., Wong P.C., and Sisodia S.S. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21 (1998) 1213-1221
47. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., and Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
48. Nee L.E., Eldridge R., Sunderland T., Thomas C.B., Katz D., Thompson K.E., Weingartner H., Weiss H., Julian C., and Cohen R. Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology 37 (1987) 359-363
49. Nishimura M., Sakamoto T., Kaji R., and Kawakami H. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci. Lett. 368 (2004) 140-143
50. Ozturk A., Desai P.P., Minster R.L., DeKosky S.T., and Kamboh M.I. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease. Neurobiol. Aging 26 (2005) 1161-1165
51. Pearson J., Huenteman M., Halperin R., Tembe W., Melquist S., Homer N., Brun M., Szelinger S., Coon K., Zismann V., Webster J., Beach T., Sando S., Aasly J., Heun R., Jessen F., Kolsch H., Tsolaki M., Daniilidou M., Reiman E., Papassotiropoulos A., Hutton M., Stephan D., and Craig D. Identification of the genetic basis for complex disorders using pooling-based genome-wide SNP association. Am. J. Hum. Genet. 80 (2006) 126-139
52. Rademakers R., Cruts M., Sleegers K., Dermaut B., Theuns J., Aulchenko Y., Weckx S., De Pooter T., Van den B.M., Corsmit E., De Rijk P., Del Favero J., van Swieten J., van Duijn C.M., and Van Broeckhoven C. Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am. J. Hum. Genet. 77 (2005) 643-652
53. Raiha I., Kaprio J., Koskenvuo M., Rajala T., and Sourander L. Alzheimer's disease in Finnish twins. Lancet 347 (1996) 573-578
54. Rao V.S., Cupples A., van Duijn C.M., Kurz A., Green R.C., Chui H., Duara R., Auerbach S.A., Volicer L., Wells J., Van Broeckhoven C., Growdon J.H., Haines J.L., and Farrer L.A. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am. J. Hum. Genet. 59 (1996) 664-675
55. Raux G., Guyant-Marechal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., and Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet. 42 (2005) 793-795
56. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., and Hyman B.T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44 (1994) 1513-1516
57. Richard F., Helbecque N., Neuman E., Guez D., Levy R., and Amouyel P. APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet 349 (1997) 539
58. Rocca W.A., and Amaducci L. The familial aggregation of Alzheimer's disease: an epidemiological review. Psychiatr. Dev. 6 (1988) 23-36
59. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerriere A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T., and Campion D. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 38 (2006) 24-26
60. Schneider L.S., Tariot P.N., and Goldstein B. Therapy with l-deprenyl (selegiline) and relation to abuse liability. Clin. Pharmacol. Ther. 56 (1994) 750-756
61. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., Gilis M., Geerts H., Kretzschmar H., Godaux E., Moechars D., Van Leuven F., and Herms J. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276 (2001) 11539-11544
62. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., and Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
63. Silverman J.M., Smith C.J., Marin D.B., Birstein S., Mare M., Mohs R.C., and Davis K.L. Identifying families with likely genetic protective factors against Alzheimer disease. Am. J. Hum. Genet. 64 (1999) 832-838
64. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993) 1977-1981
65. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.M., Jakes R., Alberts M.J., and Gilbert J.R. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125 (1994) 163-171
66. Theuns J., Brouwers N., Engelborghs S., Sleegers K., Bogaerts V., Corsmit E., De Pooter T., van Duijn C.M., De Deyn P.P., and Van Broeckhoven C. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 78 (2006) 936-946
67. van Duijn C.M., de Knijff P., Wehnert A., De Voecht J., Bronzova J.B., Havekes L.M., Hofman A., and Van Broeckhoven C. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann. Neurol. 37 (1995) 605-610
68. Walker E.S., Martinez M., Brunkan A.L., and Goate A. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios. J. Neurochem. 92 (2005) 294-301
69. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., and Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398 (1999) 513-517